Diagnosis, management and treatment of nosocomial pneumonia in ICU Serene VENTILATOR = LIFE SUPPORT but also VAP RISK. Up to 20% of ventilated patients >48 hrs develop VAP. Mortality? Can reach 50%. Here's what actually matters in ICU rounds Frontiers Oral care medications for the prevention and treatment of ventilator associated pneumonia in intensive care unit Ventilator associated pneumonia: pathobiological heterogeneity and diagnostic challenges Nature Communications ICU Ventilator Machine Manufacturer in India VapCare Exploring Ventilator Associated Pneumonia (VAP) and Its Effects on ICU Patients Market Prospects